Back to INDV
GOLDMAN SACHS GROUP INC → INDV
GOLDMAN SACHS GROUP INC INDV Position History
Indivior Pharmaceuticals, Inc.
Quarters held
22
Latest value
$248K
Q2 2026
Peak value
$154.5M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $889K |
| Q1 2025 | $582K |
| Q1 2025 | $78.3M |
| Q2 2025 | $6.7M |
| Q2 2025 | $2M |
| Q2 2025 | $132.3M |
| Q3 2025 | $154.5M |
| Q3 2025 | $4.1M |
| Q3 2025 | $1.7M |
| Q4 2025 | $217K |
| Q4 2025 | $6.9M |
| Q4 2025 | $106.9M |
| Q4 2025 | $2.5M |
| Q4 2025 | $106.9M |
| Q4 2025 | $2.5M |
| Q4 2025 | $6.9M |
| Q4 2025 | $217K |
| Q1 2026 | $66.3M |
| Q1 2026 | $7.2M |
| Q2 2026 | $14.3M |
| Q2 2026 | $14M |
| Q2 2026 | $248K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $248K | 6.0K | — | — |
| Q2 2026 | $14M | 341.9K | — | — |
| Q2 2026 | $14.3M | 348.3K | — | — |
| Q1 2026 | $7.2M | 235.1K | — | — |
| Q1 2026 | $66.3M | 2.17M | — | — |
| Q4 2025 | $217K | 6.1K | — | — |
| Q4 2025 | $6.9M | 193.6K | — | — |
| Q4 2025 | $2.5M | 70.0K | — | — |
| Q4 2025 | $106.9M | 2.98M | — | — |
| Q4 2025 | $2.5M | 70.0K | — | — |
| Q4 2025 | $106.9M | 2.98M | — | — |
| Q4 2025 | $6.9M | 193.6K | — | — |
| Q4 2025 | $217K | 6.1K | — | — |
| Q3 2025 | $1.7M | 70.0K | — | — |
| Q3 2025 | $4.1M | 168.6K | — | — |
| Q3 2025 | $154.5M | 6.41M | — | — |
| Q2 2025 | $132.3M | 8.97M | — | — |
| Q2 2025 | $2M | 133.5K | — | — |
| Q2 2025 | $6.7M | 456.8K | — | — |
| Q1 2025 | $78.3M | 8.21M | — | — |
| Q1 2025 | $582K | 61.1K | — | — |
| Q1 2025 | $889K | 93.3K | — | — |
Other funds holding INDV
$253.3M
$204.8M
$204.8M
$183.3M
$167.2M